3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma
37
Leiomyosarcoma
12
Liposarcoma
10
Sarcoma, Ewing
4
Neoplasms
4
Liposarcoma, Myxoid
4
Sarcoma, Synovial
3
Rhabdomyosarcoma
3
Histiocytoma, Malignant Fibrous
3
Sarcoma, Alveolar Soft Part
2
Ovarian Neoplasms
2
Osteosarcoma
2
Neurofibrosarcoma
2
Malignant mesenchymal tumor
2
Ichthyosis, X-Linked
2
Hemangiosarcoma
2
Hemangiopericytoma, Malignant
2
Fibrosarcoma
2
Bone Neoplasms
2
Wilms Tumor
1
Solitary Fibrous Tumors
1
Sarcoma, Endometrial Stromal
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Neoplasms, Connective and Soft Tissue
1
Neoplasms by Histologic Type
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Leiomyosarcoma Uterus
1
Hemangioendothelioma
1
Interventions
Trabectedin
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leiomyosarcoma Uterus
×
Trabectedin
×
Sarcoma
×
Clear all
NCT06524583
2025-03-30
L-UteCIN
UNICANCER
Phase 2
Recruiting
198 enrolled